Role for loss of nuclear PTEN in a harbinger of brain metastases
Open Access
- 1 October 2017
- journal article
- research article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 44, 148-154
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (16K10757)
This publication has 28 references indexed in Scilit:
- Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric GliomaPathobiology, 2016
- EGFR Mutation and Brain Metastasis in Pulmonary AdenocarcinomasJournal of Thoracic Oncology, 2014
- Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain MetastasesThe American Journal of Pathology, 2013
- ALK gene translocations and amplifications in brain metastases of non-small cell lung cancerLung Cancer, 2013
- Relevance of PTEN loss in brain metastasis formation in breast cancer patientsBreast Cancer Research, 2012
- Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastasesActa Neuropathologica, 2011
- Metastatic Behavior of Breast Cancer SubtypesJournal of Clinical Oncology, 2010
- Germline PTEN mutations in Cowden syndrome-like families.Journal of Medical Genetics, 1998
- The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-TrisphosphateJournal of Biological Chemistry, 1998
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997